QR Kodea

Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways

Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis, frequently driven by oncogenic KRAS mutations. Among these, KRAS G12D is the most prevalent, contributing to chemoresistance and limiting the efficacy of current therapeutic strategies. This study inv...

Deskribapen osoa

Gorde:
Egile Nagusiak: Hnin Ei Ei Khine, Utid Suriya, Thanyada Rungrotmongkol, Supakarn Chamni, Yanxi Lu, Alan Bénard, Bin Lan, Debabrata Mukhopadhyay, David Chang, Andrew Biankin, Regine Schneider-Stock, Robert Grützmann, Rungroch Sungthong, Christian Pilarsky, Chatchai Chaotham
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Portfolio 2025-04-01
Saila:Scientific Reports
Gaiak:
Jorunnamycin A
Pancreatic ductal adenocarcinoma
KRAS mutation
KRAS G12D
Chemotherapy
Chemosensitizer
Sarrera elektronikoa:https://doi.org/10.1038/s41598-025-95766-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak